Seropositivity to Dengue, Zika, Yellow Fever, and West Nile Viruses in Senegal, West Africa
Journal of Medical Virology · 2025
DOI: 10.1002/jmv.70338 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Medical Virology, 2025. Verfasst von Sebastian Gallon und 18 weiteren Autor:innen. Beteiligte Einrichtung: Rutgers Global Health Institute, Rutgers University, New Brunswick, New Jersey, USA. Hauptthemen laut MEDLINE: Antibodies, Viral, Yellow Fever, Zika Virus Infection, Dengue. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: The authors received no specific funding for this work..
Abstract (Originalsprache)
West Africa serves as a critical region for the co‐circulation of mosquito‐borne flaviviruses, which often precipitate sporadic outbreaks. This study investigated the seropositivity to dengue virus serotypes 1–4 (DENV‐1–4), Zika virus (ZIKV), yellow fever virus (YFV), and West Nile virus (WNV) in three regions of Senegal: Sindia, Thies, and Kedougou. We retrospectively analyzed 470 serum samples for flavivirus immunoglobulin G (IgG) using a DENV‐2 envelope (E) ELISA. Our findings revealed an overall flavivirus seroprevalence of 37.23%. Among the DENV‐2 E IgG positive samples, the proportion of subjects with IgG to DENV‐1–4, ZIKV, YFV, or WNV NS1 was 57.14%, 12.57%, 80.57%, and 17.14%, respectively, with 66.86% harboring neutralizing antibodies against two or more flaviviruses. We also identified that residents in Sindia (ZIKV, aOR, 9.428; 95% CI: 1.882–47.223 and WNV, aOR, 6.039; 95% CI: 1.855–19.658) and Kedougou (ZIKV, aOR, 7.487; 95% CI: 1.658–33.808 and WNV, aOR, 1.142; 95% CI: 0.412–3.164) were at significant risk for ZIKV and WNV exposure. This study underscores the complexity of flavivirus epidemiology in West Africa and the necessity for enhanced surveillance to inform public health strategies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Rutgers Global Health Institute, Rutgers University, New Brunswick, New Jersey, USA.
- Department of Medicine, Division of Allergy, Immunology, and Infectious Diseases and Child Health Institute of New Jersey, Rutgers Robert Wood Johnson Medical School, New Brunswick, New Jersey, USA.
- International Research Training Center on Genomics and Health Surveillance (CIGASS), Cheikh Anta Diop University, Dakar, Senegal.
- Laboratoire d'Ecologie Vectorielle et Parasitaire, Cheikh Anta Diop University, Dakar, Senegal.
ORCID-Profile: Bobby Brooke Herrera
Förderung
- The authors received no specific funding for this work.
Zitieren
APA
Gallon, S., Sy, M., Tonto, P. B., Ndiaye, I. M., Toure, M., Gaye, A., Aidara, M., Mbaye, A. M., Dia, A. K., Diallo, M. A., Gomis, J. F., Yade, M. S., Diedhiou, Y., Dieye, B., Diongue, K., Seck, M. C., Badiane, A. S., Ndiaye, D., & Herrera, B. B. (2025). Seropositivity to Dengue, Zika, Yellow Fever, and West Nile Viruses in Senegal, West Africa. Journal of Medical Virology. https://doi.org/10.1002/jmv.70338
Vancouver
Gallon S, Sy M, Tonto PB, Ndiaye IM, Toure M, Gaye A, et al. Seropositivity to Dengue, Zika, Yellow Fever, and West Nile Viruses in Senegal, West Africa. Journal of Medical Virology. 2025. doi:10.1002/jmv.70338
BibTeX
@article{Gallon2025,
author = {Gallon, Sebastian and Sy, Mouhamad and Tonto, Prince Baffour and Ndiaye, Ibrahima Mbaye and Toure, Mariama and Gaye, Amy and Aidara, Mariama and Mbaye, Amadou Moctar and Dia, Abdoulaye Kane and Diallo, Mamadou Alpha and Gomis, Jules Francois and Yade, Mamadou Samb and Diedhiou, Younous and Dieye, Baba and Diongue, Khadim and Seck, Mame Cheikh and Badiane, Aida S and Ndiaye, Daouda and Herrera, Bobby Brooke},
title = {Seropositivity to Dengue, Zika, Yellow Fever, and West Nile Viruses in Senegal, West Africa},
journal = {Journal of Medical Virology},
year = {2025},
doi = {10.1002/jmv.70338}
}
EUVIMED